Leica Biosystems completes acquisition of StatLab to bolster delivery of more precise, timely diagnostics for cancer patients
Leica Biosystems, a Danaher company (the “Company”) and a global leader in digital and anatomic pathology solutions advancing precision cancer diagnostics, announced today that the Company has completed its acquisition of privately held StatLab Medical Products (“StatLab”).
Read original article on The Medical News →Related news
-
New AI tool can predict where glioblastoma is most likely to return after initial surgery
United Kingdom
-
New method automatically maps myelin patterns in the brain, revealing signs of injury
United Kingdom
-
165,000+ pounds of pork, beef and goat recalled over USDA inspection mark
United Kingdom
-
Childhood cancer survivors face severe mental health challenges as adults
United Kingdom
-
New framework maps the complex link between psychological status and cardiovascular health
United Kingdom
-
Brain stimulation could reshape how you learn new skills
United Kingdom
-
Pre-exercise caffeine enhances repeated sprint performance for at least 3.5 hours
United Kingdom
-
People fitted with synthetic owl ears learn to localize sound (a little) better
United Kingdom